Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 50 results in range #501 to #550.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. Dose rate effectiveness factor‏‎ (2 revisions)
  2. Emergency plan‏‎ (2 revisions)
  3. Ethics‏‎ (2 revisions)
  4. ALARA‏‎ (2 revisions)
  5. Activity‏‎ (2 revisions)
  6. Prevailing circumstances‏‎ (2 revisions)
  7. High level waste‏‎ (2 revisions)
  8. Radon Recommendations for Authorities‏‎ (2 revisions)
  9. Reference individual‏‎ (2 revisions)
  10. Clearance‏‎ (2 revisions)
  11. Remedial action‏‎ (2 revisions)
  12. ICRPædia Guide to Dose Coefficients‏‎ (2 revisions)
  13. Deontological Ethics‏‎ (2 revisions)
  14. Intervention Level‏‎ (2 revisions)
  15. Differentiation‏‎ (2 revisions)
  16. Substantial radiation dose level‏‎ (2 revisions)
  17. Transfer rate‏‎ (2 revisions)
  18. Multi-detector computed tomography‏‎ (2 revisions)
  19. Percutaneous coronary intervention‏‎ (2 revisions)
  20. Principle of application of dose limits‏‎ (2 revisions)
  21. Radioactivity‏‎ (2 revisions)
  22. Beta-minus decay‏‎ (2 revisions)
  23. Radon Recommendations for Workplaces‏‎ (2 revisions)
  24. Reference level‏‎ (2 revisions)
  25. Clearance level‏‎ (2 revisions)
  26. Remediation‏‎ (2 revisions)
  27. Risk of Exposure to Radon‏‎ (2 revisions)
  28. South Atlantic anomaly‏‎ (2 revisions)
  29. Interventional procedure‏‎ (2 revisions)
  30. Dose constraint‏‎ (2 revisions)
  31. Lymphatic system‏‎ (2 revisions)
  32. Early normal tissue responses‏‎ (2 revisions)
  33. Transforming growth factor‏‎ (2 revisions)
  34. Pericarditis‏‎ (2 revisions)
  35. Growth factor‏‎ (2 revisions)
  36. Alimentary tract transfer factor‏‎ (2 revisions)
  37. Beta-plus decay‏‎ (2 revisions)
  38. Calculating Doses from Intakes of Radionuclides‏‎ (2 revisions)
  39. Repopulation‏‎ (2 revisions)
  40. Routine monitoring‏‎ (2 revisions)
  41. ICRPædia Guide to Radon‏‎ (2 revisions)
  42. Cumulative dose‏‎ (2 revisions)
  43. Special (non-routine) monitoring‏‎ (2 revisions)
  44. Lifetime risk‏‎ (2 revisions)
  45. Dose conversion coefficient‏‎ (2 revisions)
  46. Macrophage colony stimulating factor‏‎ (2 revisions)
  47. Edema‏‎ (2 revisions)
  48. Multiplicative risk projection model‏‎ (2 revisions)
  49. Excess relative risk‏‎ (2 revisions)
  50. Exposure situation‏‎ (2 revisions)

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)